Merck is recalling about 276,000 bottles of Temodar (temozolomide) and generic temozolomide capsules because the bottle caps can crack. These oral chemotherapy drugs were distributed in 5- and 14-count brown glass bottles with white plastic caps between July 2013 and August 2015. Consumers should inspect their bottle caps immediately and contact the manufacturer for a replacement if a crack is found, though they may continue taking the medication as directed by their doctor.
A cracked cap can cause the child-resistant closure to fail, allowing young children to open the bottle and access the capsules. This poses a serious risk of accidental poisoning from these chemotherapy medications.
Consumers should immediately inspect their bottle caps for cracks. If a crack is found, consumers should contact Merck for a replacement cap. As with all drug products, the bottles should be stored up high, out of sight and reach of young children. Consumers may continue to use the drug as directed.
Temodar® (Temozolomide)
Close up view of the Temozolomide Capsules cracked cap rendering the child-resistant closure ineffective
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response